Authors:
HOLSCHBACH M
BOY C
HERZOG H
WUTZ W
SCHMITZ T
MUHLENSIEPEN H
SHAH J
MULLERGARTNER HW
OLSSON RA
COENEN HH
Citation: M. Holschbach et al., PRECLINICAL EVALUATION OF THE NEW A(1) ADENOSINE RECEPTOR (A(1)AR) ANTAGONIST [F-18] 8-CYCLOPENTYL-1-PROPYL-3-(3-FLUOROPROPYL)XANTHINE ([F-18]CPFPX), The Journal of nuclear medicine, 39(5), 1998, pp. 77-77
Authors:
HERZOG H
HOLSCHBACH M
BOY C
WUTZ W
SCHMITZ T
MUHLENSIEPEN H
MULLERGARTNER HW
OLSSON RA
COENEN HH
Citation: H. Herzog et al., BIODISTRIBUTION AND RADIATION-DOSE OF THE NEW A(1) ADENOSINE RECEPTORANTAGONIST [F-18] CPFPX IN MICE AND BABOON, The Journal of nuclear medicine, 39(5), 1998, pp. 846-846
Authors:
BOY C
HOLSCHBACH M
MUHLENSIEPEN H
HERZOG H
SHAH J
GROSSERUYKEN M
SCHMITZ T
CREMER M
OLSSON RA
MULLERGARTNER HW
COENEN H
Citation: C. Boy et al., MAPPING A(1)-ADENOSINE RECEPTORS (A(1)AR) IN THE LIVING PRIMATE BRAINUSING THE NOVEL A(1)AR-ANTAGONIST [F-18] CPFPX AND PET, The Journal of nuclear medicine, 39(5), 1998, pp. 1017-1017
Authors:
BELARDINELLI L
SHRYOCK JC
SNOWDY S
ZHANG Y
MONOPOLI A
LOZZA G
ONGINI E
OLSSON RA
DENNIS DM
Citation: L. Belardinelli et al., THE A(2A) ADENOSINE RECEPTOR MEDIATES CORONARY VASODILATION, The Journal of pharmacology and experimental therapeutics, 284(3), 1998, pp. 1066-1073
Authors:
HOLSCHBACH MH
FEIN T
KRUMMEICH C
LEWIS RG
WUTZ W
SCHWABE U
UNTERLUGAUER D
OLSSON RA
Citation: Mh. Holschbach et al., A(1) ADENOSINE RECEPTOR ANTAGONISTS AS LIGANDS FOR POSITRON-EMISSION-TOMOGRAPHY (PET) AND SINGLE-PHOTON EMISSION TOMOGRAPHY (SPET), Journal of medicinal chemistry, 41(4), 1998, pp. 555-563
Citation: Rj. Shaw et Ra. Olsson, ADDRESSING THE SHORTCOMINGS OF TRADITIONAL FORMAL REASONING METHODS FOR CONCURRENT PROGRAMS - NEW TOOLS AND TECHNIQUES FOR SOURCE CODE CORRECTNESS, Information sciences, 106(3-4), 1998, pp. 259-275
Authors:
SZENTMIKLOSI AJ
CSEPPENTO A
UJFALUSI A
SZABO JZ
KOVACS P
OLSSON RA
Citation: Aj. Szentmiklosi et al., PHARMACOLOGICAL CHARACTERIZATION OF ADENOSINE RECEPTORS IN RAT PULMONARY-ARTERY, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 26-26
Authors:
SCAMMELLS PJ
BAKER SP
BELLARDINELLI L
OLSSON RA
RUSSELL RA
KNEVITT SA
Citation: Pj. Scammells et al., THE DESIGN AND SYNTHESIS OF NOVEL ADENOSINE AGONISTS, Bioorganic & medicinal chemistry letters, 6(7), 1996, pp. 811-814
Authors:
COULSON R
PROCH PS
OLSSON RA
CHALFANT CE
COOPER DR
Citation: R. Coulson et al., UP-REGULATED RENAL ADENOSINE A(1) RECEPTORS AUGMENT PKC AND GLUCOSE-TRANSPORT BUT INHIBIT PROLIFERATION, American journal of physiology. Renal, fluid and electrolyte physiology, 39(2), 1996, pp. 263-274
Citation: Ww. Ho et Ra. Olsson, A LAYERED MODEL FOR BUILDING DEBUGGING AND MONITORING TOOLS, The Journal of systems and software, 34(3), 1996, pp. 211-222
Authors:
HOLSCHBACH M
FEIN T
WUTZ W
SCHULLER M
HAMACHER K
LEWIS R
SCHWABE U
STOCKLIN G
OLSSON RA
Citation: M. Holschbach et al., NCA RADIOLABELED A(1) ADENOSINE RECEPTOR ANTAGONISTS AS LIGANDS FOR PET AND SPECT, The Journal of nuclear medicine, 37(5), 1996, pp. 625-625
Authors:
PUKETZA NJ
ZHANG K
CHUNG M
MUKHERJEE B
OLSSON RA
Citation: Nj. Puketza et al., A METHODOLOGY FOR TESTING INTRUSION DETECTION SYSTEMS, IEEE transactions on software engineering, 22(10), 1996, pp. 719-729
Authors:
SCAMMELLS PJ
BAKER SP
BELLARDINELLI L
OLSSON RA
RUSSELL RA
WRIGHT DMJ
Citation: Pj. Scammells et al., THE SYNTHESIS OF THE NOVEL ADENOSINE AGONISTS, EXO-N-6-(5,6-EPOXYNORBORN-2-YL)ADENOSINE AND ENDO-N-6-(5,6-EPOXYNORBORN-2-YL)ADENOSINE, Tetrahedron, 52(13), 1996, pp. 4735-4744
Citation: Ra. Olsson et Cm. Mcnamee, EXPERIENCE USING THE C-PREPROCESSOR TO IMPLEMENT CCR, MONITOR, AND CSP PREPROCESSORS FOR SR, Software, practice & experience, 26(2), 1996, pp. 125-134
Authors:
VANDERPLOEG I
AHLBERG S
PARKINSON FE
OLSSON RA
FREDHOLM BB
Citation: I. Vanderploeg et al., FUNCTIONAL-CHARACTERIZATION OF ADENOSINE A(2) RECEPTORS IN JURKAT CELLS AND PC12 CELLS USING ADENOSINE RECEPTOR AGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 353(3), 1996, pp. 250-260
Authors:
LUTHIN DR
OLSSON RA
THOMPSON RD
SAWMILLER DR
LINDEN J
Citation: Dr. Luthin et al., CHARACTERIZATION OF 2 AFFINITY STATES OF ADENOSINE-A(2A) RECEPTORS WITH A NEW RADIOLIGAND, -(4-AMINO-3-[I-125]IODOPHENYL)ETHYLAMINO]ADENOSINE, Molecular pharmacology, 47(2), 1995, pp. 307-313
Citation: R. Coulson et al., UP-REGULATION OF PROXIMAL ADENOSINE-A1-RECEPTOR (A1-R), PKC AND GLUCOSE-TRANSPORT BY CHRONIC CAFFEINE OR CPT, Journal of the American Society of Nephrology, 5(3), 1994, pp. 712-712
Authors:
CRISTALLI G
VITTORI S
THOMPSON RD
PADGETT WL
SHI D
DALY JW
OLSSON RA
Citation: G. Cristalli et al., INHIBITION OF PLATELET-AGGREGATION BY ADENOSINE RECEPTOR AGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 349(6), 1994, pp. 644-650
Citation: K. Niiya et al., GLIBENCLAMIDE REDUCES THE CORONARY VASOACTIVITY OF ADENOSINE RECEPTORAGONISTS, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 14-19
Authors:
TSUCHIDA A
THOMPSON R
OLSSON RA
DOWNEY JM
Citation: A. Tsuchida et al., THE ANTI-INFARCT EFFECT OF AN ADENOSINE A(1)-SELECTIVE AGONIST IS DIMINISHED AFTER PROLONGED INFUSION AS IS THE CARDIOPROTECTIVE EFFECT OF ISCHEMIC PRECONDITIONING IN RABBIT HEART, Journal of Molecular and Cellular Cardiology, 26(3), 1994, pp. 303-311